Results 1 to 10 of about 112,020 (111)

Vulvovaginal atrophy in postmenopausal women: diagnosis and modern-day treatments

Лечащий Врач, 2022
The article is devoted to the study of modern methods of diagnosis and treatment of benign diseases of the vulva and vagina in postmenopausal women.
K. R. Bahtiyarov, R. A. Chilova, Sh. Sh. Sardarova   +2 more
doaj   +2 more sources

Management of patients with vulvovaginal atrophy and cytological abnormalities [PDF]

Гинекология, 2023
The data on managing patients with vulvovaginal atrophy and abnormal cytological results are provided for obstetrician-gynecologists.
Niso M. Nazarova, Vera N. Prilepskaya, Anna N. Mgeryan, Elmira R. Dovletkhanova, Patimat R. Abakarova, Elena A. Mezhevitinova   +5 more
doaj   +2 more sources

GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy – study protocol

BMJ Open, 2023
Introduction Breast cancer is the most common cancer type in women worldwide. Due to hormone receptor positivity in the majority of the breast cancer tumours is endocrine therapy a crucial part in the treatment landscape of breast cancer.
Glenn Vergauwen, Hannelore Denys, Piet Cools, Hans Verstraelen, Koen van de Vijver, Tom Fiers, Liv Veldeman   +6 more
doaj   +3 more sources

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy

Frontiers in Reproductive Health, 2021
The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect ...
Pedro Vieira-Baptista, Ayane Cristine Sarmento, Ana Paula Ferreira Costa   +2 more
exaly   +3 more sources

The Role of Topical Treatment on Vaginal Tightening

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2022
Background: Physiological changes in a woman's life, such as labor, weight fluctuations, hormonal changes, aging, and menopause, cause changes in both appearance and function of the vagina.
Made Putri Hendaria
doaj   +1 more source

Vulvovaginal atrophy: issues of treatment and rehabilitation: A review [PDF]

Гинекология, 2022
The review presents data on the management tactics of women with vulvovaginal atrophy in patients of reproductive age and menopause. The influence of vulvovaginal atrophy on the psycho-emotional and sexual spheres, modern methods of diagnosis and therapy
Diana M. Ampilogova, Antonina G. Solopova, Dmitry V. Blinov, Evgeny E. Achkasov, Daria A. Petrenko, Daniil I. Korabelnikov   +5 more
doaj   +1 more source

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

Menopause Review, 2021
During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep.
Wojciech Pięta, Roman Smolarczyk
doaj   +1 more source

Safety and Feasibility of Autologous Micro-Fragmented Adipose Tissue Injections for the Treatment of Vaginal Atrophy, Vulvovaginal Dystrophy, and Stress Urinary Incontinence: An Observational Case Series

European Medical Journal Urology, 2020
Objective: Vaginal atrophy, vulvovaginal dystrophy, and stress urinary incontinence (SUI), common conditions in women, have detrimental effects on quality of life.
Laura Stark, Mira Razzaque, Jeannie Yoon, Mehrnoosh Aref-Adib, Miles Banwell, Shohreh Beski   +5 more
doaj   +1 more source

Current management of vaginal dryness [PDF]

РМЖ. Мать и дитя, 2021
T.V. Tazina1, A.V. Knyazeva2, T.V. Bebneva3,4 1Ryazan State Medical University, Ryazan, Russian Federation 2Regional Clinical Hospital, Ryazan, Russian Federation 3Russian University of Peoples’ Friendship, Moscow, Russian Federation ...
T.V. Tazina, A.V. Knyazeva, T.V. Bebneva
doaj   +2 more sources

THE EFFECTIVENESS OF PRASTERONE VS PLACEBO THERAPY AS THE VULVOVAGINAL ATROPHY TREATMENT IN MENOPAUSAL WOMEN: META-ANALYSIS STUDY

Medical and Health Science Journal, 2020
Background : Vulvovaginal atrophy is a condition that often occurs in menopausal women due to Estrogen decreased. Prasterone (DHEA) is a steroid hormone that can be converted into Estrogen in the target tissue.
Zettira Maulida Prasha, Hari Paraton
doaj   +1 more source